Persistent Epstein-Barr virus infection in the common marmoset (Callithrix jacchus)

Journal of General Virology

Volumn 77, Issue 6, 1996, Pages 1173-1180

  Cox, C ^a   Chang, S ^a   Karran, L ^b   Griffin, B ^b   Wedderburn, N ^a  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PILOCARPINE; VIRUS ANTIGEN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MARMOSET; MOUTH; NONHUMAN; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALIVA; VIRUS INFECTIVITY; VIRUS SHEDDING;

ANIMALIA; CALLITHRIX JACCHUS; DNA VIRUSES; HUMAN HERPESVIRUS 4; MARMOSETS;

EID: 0030010966     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-6-1173     Document Type: Article

References (47)

1. ARRAND, J. R (1992). Prospects for a vaccine against Epstein-Barr virus. Cancer Journal 5, 188-193.
2. BAER, R., BANKIER, A. T., BIGGIN, M. D., DEININGER, P L., FARRELL, P. J., GIBSON, T. J., HATFULL, G., HUDSON, G. S., SATCHWELL, S. C., SEGUIN, C., TUFFNELL, P. & BARRELL. B. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
3. CROUSE, C. A., BAN, J. D & D'ALESSIO, J. K. (1993). Extraction of DNA from forensic-type sexual assault specimens using simple, rapid sonication procedures. BioTechniques 15, 641-644.
4. DE FRANCHIS, R., CROSS, N. C. P., FOULKES, N. S. & COX, T. M. (1988). A potent inhibitor of Taq polymerase copurifies with human genomic DNA. Nucleic Acids Research 16, 10355.
5. DESGRANGES, C., LENOIR, G., DE THÉ, G., SEIGNEURIN, J. M., HILGERS, J. & DUBOUCH, P (1976). In vitro transforming activity of EBV 1. Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine 25, 349-352.
6. DESGRANGES, C., LAVOUÉ, M. F., PATET, J. & DE THÉ, G. (1979). In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains Biomedicine 30, 102-108.
7. DE THÉ, G., HO, H. C , KWAN, H. C., DESGRANGES, C. & FAVRE, M. C. (1970). Nasopharyngeal carcinoma (NPC). 1. Type of cultures derived from tumour biopsies and non-tumerous tissues of Chinese patients with special reference to lymphoblastoid transformation International Journal of Cancer 6, 189-206.
8. DE THÉ, G., GESER, A., DAY, N. E., TURKEI, P. M., WILLIAMS, E. H., BERI, D. P., SMITH, P G., DEAN, A. G., BORNKAMM, G. W., FEORINO, P. & HENLE, W (1978). Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan Prospective Study. Nature 274, 756-761.
9. DE THÉ, G., DUBOUCH, P.. FONTAINE, C., WEDDERBURN, N., CARTER, R. L , EDWARDS, M. B. & COHEN, B. (1980). Natural antibodies to EBV-VCA antigens in common marmosets (Callithrix jacchus) and response after EBV inoculation. Intervirology 14, 284-291.
10. EMINI, E. A., LUKA, J., ARMSTRONG, M. E., BANKER, F. S., PROVOST, P. J. & PEARSON, G. R. (1986). Establishment and characterization of a chronic infectious mononucleosis-like syndrome in common marmosets. Journal of Medical Virology 18, 369-379.
11. EPSTEIN, M. A. (1976). Epstein-Barr virus-is it time to develop a vaccine program? Journal of the National Cancer Institute 56, 697-700.
12. EPSTEIN, M. A., MORGAN, A. J., FINERTY, S., RANDLE, B. J. & KIRKWOOD, J. K (1985). Protection of cotton top tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318, 287-289.
13. FELTON, S. C., HOFFMANN, C. C., KREIER. J. P. & GLASER, R. (1984). Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus. Laboratory Animal Science 34, 164-168.
14. FINERTY, S., TARLTON, J., MACKETT, M., CONWAY, M., ARRAND, J. R., WATKINS, P. E. & MORGAN, A. J. (1992). Protective immunization against Epstein-Barr virus-induced disease in cotton top tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector. Journal of General Virology 73, 449-453.
15. FRIED, M. W., SHINDO, M., FONG, T., Fox, P. C., HOOFNAGLE, J. H. & BISCEGLIE, M. D. (1992). Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology 102, 1306-1308.
16. GREENSPAN, J. S., GREENSPAN, D., LENNETTE, E. T , ABRAMS, D. I., COGNANT, M. A., PETERSON, V. & FREESE, U. K. (1985). Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313, 1564-1571.
17. GREENSPAN, D., GREENSPAN, J. S., DE SOUZA, Y., LERY, J. A. & UNGAR, A. M. (1989). Oral hairy leukoplakia in an HIV negative renal transplant recipient. Journal of Oral Palhology and Medicine 18, 32-34.
18. HANTO, D. W., FRIZZERA, G., PURTILO, D. T., SAKAMOTO, K., SULLIVAN, J. L., SAEMUNDSEN, A. K., KLEIN, G., SIMMONS, R. L. & NAJARIAN, J. S. (1981). Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Research 41, 4253-4261.
19. HENLE, G. & HENLE, W. (1966). Immunofluorescence in cells derived from Burkitt's lymphoma. Journal of Bacteriology 91, 1248-1256.
20. HENLE, W., HENLE, G., ZAJAC, B. A., PEARSON, G., WAUBKE, R. & SCRIBA, M. (1970). Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169, 188-190.
21. HENLE, W., HENLE. G. & KLEIN, G. (1971). Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells International Journal of Cancer 8, 272-282.
22. HERBST, H., NIEDOBITEK, G., KNEBA, M., HUMMEL, M., FINN, T., ANAGNOSTOPOULOS, L, BERGHOLZ, M., KRIEGER, G. & STEIN, H. (1990). High incidence of Epstein-Barr virus genomes in Hodgkin's disease. American Journal of Pathology 137, 13-18.
23. Ho, J. H. C. (1972). Current knowledge of the epidemiology of nasopharyngeal carcinoma - a review. In Oncogenesis and Herpesviruses, pp. 357-366. Edited by P. M. Biggs, G. de Thé & L. N. Payne. Lyon: IARC.
24. IMAI, S., KOIZUMI, S., SUGIURA, M., TOKUNAGA, M., UEMURA, Y., YAMAMOTO, N., TANAKA, S., SATO, E. & OSATO, T. (1994). Gastric carcinoma: monoclonal epithelial malignant cells expressing EpsteinBarr virus latent infection protein. Proceedings of the National Academv of Sciences, USA 91, 9131-9135.
25. ISRAELE, V., SHIRLEY, P. & SIXBEY, J. W. (1991). Excretion of the Epstein-Barr virus from the genital tract of men. Journal of Infectious Diseases 163, 1341-1343.
26. JOHNSTON, D. A., KNIGHT, A M., NAYLOR, B. A., WEDDERBURN, N. & MITCHELL, G. H. (1990). Monoclonal antibodies from Epstein-Barr virus-transformed lymphocytes of common marmosets (Callithrix jacchus) immune to malaria. Journal of Immunological Methods 127, 187-195.
27. JUNKER. A K., THOMAS, E. E., RADCLIFFE, A., FORSYTH. R. B., DAVIDSON, A G. F. & RYMO, L. (1991). Epstein-Barr virus shedding in breast milk American Journal of Medical Sciences 302, 220-223.
28. KHAN, G., KANGRO, H O., COATES, P. J. & HEATH, R. B. (1991). Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. Journal of Clinical Pathology 44, 360-365.
29. LABRECQUE, L G., BARNES. D M., FENTIMAN, I S. & GRIFFIN, B. E (1995). Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Research 55, 39-45.
30. LANDAU, Z., GROSS, R., SANILEVICH, A., FRIEDMANN, A. & MITRANIROSENBAUM, S. ( 1994) Presence of infective Epstein-Barr virus in the urine of patients with infectious mononucleosis. Journal of Medical Virology 44, 229-233.
31. LIOU, T., CHANG, T., YOUNG. K., LIN, X., LIN, C. & Wu, H. (1992). Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. Journal of Medical Virology 31, 197-202.
32. MORGAN, A. J., ALLISON, S., FINERTY, S., SCULLION, F. T., BYARS, N. E & EPSTEIN, M. A. (1989). Validation of a first-generation Epstein-Barr virus preparation suitable for human use. Journal of Medical Virology 29, 74-78.
33. NIEDOBITEK, G., AGATHANGGELOU, A., FlNERTY, S., TIERNEY. R., WATKINS, P., JONES, E. L., MORGAN, A., YOUNG, L. S. & ROONEY, N. (1994) Latent Epstein-Barr virus infection in cottontop tamarins. American Journal of Pathology 145, 969-978.
34. NOORDHOEK, G. T., KOLK, A. H. J., BJUNE, G., CATTY, D., DALE, J. W., FINE, P. E. M., GODFREY-FAUSSETT, P., CHO, S., SHINNICK, T., SVENSON, S. B., WILSON, S. & VAN EMBDEN, J. D. A. (1994). Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. Journal of Clinical Microbiology 32, 277-284.
35. OCHERT, A. S., BOULTER, A. W., BIRNBAUM, W., JOHNSON, N. W. & TEO, C. G. (1994a). Inhibitory effect of salivary fluids on PCR: potency and removal. PCR Methods and Applications 3, 365-368.
36. OCHERT, A., SLOMKA, M. J., ELLIS, J. & TEO, C. G (1994e). Use of Chelex® 100 in the extraction of viruses from diverse cell-free clinical samples for PCR. Edited by A. Rolfs, I. Weber-Rolfs & U Finckh. In Methods in DNA Amplification, pp. 47-53. London: Plenum Press.
37. PEDNEAULT, L. & KATZ, B. Z. (1993). Comparisons of polymerase chain reaction and standard Southern blotting for the detection of Epstein-Barr virus DNA in various biopsy specimens. Journal of Medical Virology 39, 33-43.
38. PUCHHAMMER-STÖCKL, E., MOR, W., KUNDI, M., HEINZ, F. X., HOFMANN, H. & KUNZ, C. (1994). Prevalence of hepatitis-C virus RNA in serum and throat washings of children with chronic hepatitis. Journal of Medical Virology 43, 143-147.
39. RICKINSON, A. B., ROWE, M., HART, I. J., YAO, Q. Y., HENDERSON, L. E., RABIN, H. & EPSTEIN, M. A. (1984). T-cell mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with Cyclosporin A. Cellular Immunology 87, 646-658.
40. SIXBEY, J. W., LEMON, S. M. & PAGANO, J. S. (1986). A second site for Epstein-Barr virus shedding : the uterine cervix. Lancet ii, 1122-1124.
41. TAKAMATSU, K., KOYANAGI, Y., OKITA, K. & YAMAMOTO, N. (1990). Hepatitis C virus RNA in saliva. Lancet 336, 1515.
42. THOMAS, J. A. & CRAWFORD, D. H (1989). Epstein-Barr virusassociated B-cell lymphomas in AIDS and after organ transplantation. Lancet i, 1075-1076.
43. VAN ZWET, A. A., THUS, J. C., KOOISTRA-SMID, A. M D., SCHIRM, J. & SNIJDER, J. A. M (1994). Use of PCR with feces for detection of Helicobacter pylori infections in patients. Journal of Clinical Microbiology 32, 1346-1348.
44. WALSH, P. S., METZGER, D. A. & HIGUCHI, R. (1991). Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 10, 506-513.
45. WEDDERBURN, N., EDWARDS, J. M. B., DESGRANGES, C., FONTAINE. C., COHEN, B. & DE THÉ. G. (1984). Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. Journal of Infectious Diseases 150, 878-882
46. YAO, Q. Y., RICKINSON, A. B. & EPSTEIN. M. A. (1985). A reexamination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer 35, 35-42.
47. ZUR HAUSEN, H., SCHULTE-HOLTHAUSEN, H., KLEIN, G., HENLE, W., HENLE. G., CLIFFORD, P. & SANTESSON, L. (1970). EB-virus DNA m biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228, 1056-1058.